A new technique may help characterize diffusion anisotropy in the spinal cord in a clinical setting. Researchers have determined that using 3D single-shot diffusion-weighted stimulated echo-planar imaging in the cervical spinal cord results in higher resolution and less distortion than 2D single-shot diffusion-weighted echo-planar imaging.
Although diffusion-weighted imaging has been useful to obtain information about the brain, the technique has been little used for the spinal cord, said Dr. Majda Thurnher, a researcher with the Medical University of Vienna.
While MRI has been the modality of choice for detection of spinal cord diseases, it is limited by its high sensitivity and low specificity, she said.
The studies were performed on a 3T system. Three-D single-shot diffusion-weighted stimulated echo-planar imaging (ss-DWSTEPI) was applied to obtain images of a localized volume from the midbrain to the cervical cord of 10 healthy volunteers.
DWI was performed in the sagittal plane with isotropic resolution over seven minutes and 12 slice locations, with b = 0 and 500 sec/mm2 along 12 noncollinear diffusion encoding directions and eight magnitude averages at each direction. These diffusion-weighted images were postprocessed using diffusion-tensor imaging analysis software to obtain the fractional anisotropy and to visualize the principal eigenvector and fiber tracts.
Results produced with high-resolution sagittal DTI using 3D ss-DWSTEPI provided contiguous coverage of the spinal cord with shorter echo-train length, and therefore reduced distortion artifact, than those obtained with 2D single-shot diffusion-weighted echo-planner imaging (ss-DWEPI).
DTI measurements in the spinal cord using 3D ss-DWSTEPI may help in the diagnosis and treatment of spinal cord trauma, degenerative and inflammatory conditions, cord demyelination, and tumors.
Clinical applications include the treatment of spinal cord ischemia, multiple sclerosis, HIV myelopathy, transverse myelitis, spondylosis, spinal cord tumors, ependymoma, astrocytoma, hemangioblastoma, ependymoma, and spinal cord injury.
In a related study, 20 healthy volunteers underwent MRI at 3T. Both transverse and sagittal DTI were performed using single-shot spin-echo echo-planar imaging.
Researchers found the fractional anisotropy values of the cervical spinal cord were significantly higher with axial DTI than with sagittal DTI in the central cord. Given the higher standard deviations of fractional anisotropy and apparent diffusion coefficient values with sagittal DTI in all measured regions, axial DTI may provide more accurate values and may be more desirable for comparative studies between patients and healthy controls.
In the comparison of DTI studies, possible differences in DTI metrics due to either axial or sagittal imaging must be taken into account, according to the researchers.
|
DiagnosticImaging.com. Diffusion tensor imaging measurements may help diagnosis of spinal cord trauma
By Donna Domino |
November 30, 2008
RSNA 2008 November 30
Following simple steps can minimize risk of being sued
November 30, 2008 Legal and regulatory issues have a growing impact on how radiologists perform procedures and studies, report results, and structure their practices. Implementing a simple checklist may help to reduce the prospect of being sued for malpractice. Standardized chemoembolization protocol boosts liver cancer patient survival
November 30, 2008 Results from the largest and longest trial of its kind suggest that patients with intermediate and advanced hepatocellular carcinomas who undergo systematic treatment with three chemotherapeutic agents and arterial embolization plus imaging follow-up have better survival rates than those who undergo nonstandardized chemoembolization regimes. Lung cancer staging undergoes major overhaul
November 30, 2008 The imminent publication of eagerly anticipated new international guidelines promises to transform the complex area of lung cancer staging. PET/CT in prostate cancer influences staging, treatment strategy
November 30, 2008 Prostate-specific antigen measurements are considered a useful organ-specific marker, but they are not necessarily an adequate tumor marker. PET/CT in combination with PSA levels can play a significant role in detecting and staging prostate cancer, according to two presentations Sunday at RSNA 2008. Diffusion tensor imaging measurements may help diagnosis of spinal cord trauma
November 30, 2008 A new technique may help characterize diffusion anisotropy in the spinal cord in a clinical setting. Researchers have determined that using 3D single-shot diffusion-weighted stimulated echo-planar imaging in the cervical spinal cord results in higher resolution and less distortion than 2D single-shot diffusion-weighted echo-planar imaging. Learning never stops in globalized world of healthcare
November 30, 2008 Lifelong learning in an era of globalized healthcare science and practice is essential, according to Sunday’s opening session of RSNA 2008, which also stressed the need for standardization in training and certification. SuperSonic builds on breast elastrography
November 30, 2008 Elastrography forms the cornerstone of an ultrasound system unveiled by first-time RSNA exhibitor SuperSonic Imagine. The Aixplorer system is dedicated to breast imaging. It differentiates healthy from cancerous tissues by quantifying differences in the elasticity of the tissues. SuperSonic’s ShearWave Elastography technique produces consistent results regardless of the operator’s skill, according to the company. Philips ultrasound upgrade targets breast imaging
November 30, 2008 Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies. Naviscan readies PET biopsy
November 30, 2008 PET niche developer Naviscan arrived at the RSNA meeting with permission from the FDA to launch its Stereo Navigator, a biopsy guidance feature for its breast-specific PET scanner. Stereo Navigator can localize lesions as small as 2 mm. It uses a stereotactic frame fixed between the scanner’s paddles to guide a biopsy needle into the breast. Localization is verified using a PET-visible line source inserted into the needle track. This allows the user to confirm trajectory and position. The PET-guidance accessory is compatible with biopsy devices from Ethicon Endo-Surgery, Hologic, and SenoRx. Invivo unveils next-generation MR-compatible monitor
November 30, 2008 Invivo introduced at RSNA 2008 its sixth-generation vital signs monitor for use in MR suites. The Precess Patient Management Configuration uses the industry’s first wireless ECG and wireless SpO2 patient vital signs. Built on the company’s flagship Precess 3160 platform, the new system features a flexible mounting that allows attachment to anesthesia machines, a wall, or an MRI table. |
|
